Related Experiment Video
Updated: Jun 20, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Recurrent pneumothorax developing during chemotherapy in a patient with miliary tuberculosis
Prem Parkash Gupta1, Dinesh Mehta, Dipti Agarwal
1Department of Respiratory Medicine, Postgraduate Institute of Medical Sciences, Rohtak, India. gparkas@yahoo.co.in
Annals of Thoracic Medicine
|September 4, 2009
Summary
Miliary tuberculosis (MTB) is common, but pneumothorax during MTB treatment is rare. This case highlights the diagnostic challenges and potential dangers of delayed pneumothorax identification in patients with MTB.
Area of Science:
- Pulmonology
- Infectious Diseases
- Critical Care Medicine
Background:
- Miliary tuberculosis (MTB) is a severe disseminated form of tuberculosis.
- Antitubercular chemotherapy is the standard treatment for MTB.
- Pneumothorax is a rare but serious complication during MTB treatment.
Observation:
- A 24-year-old female patient with miliary tuberculosis developed recurrent pneumothorax.
- Symptoms of pneumothorax were masked by miliary tuberculosis symptoms.
- This led to a delay in diagnosing the pneumothorax.
Findings:
- Pneumothorax can be life-threatening in the context of miliary tuberculosis.
- The overlapping symptoms can obscure the diagnosis of pneumothorax.
- Recurrent pneumothorax occurred despite ongoing antitubercular chemotherapy.
Implications:
- Increased vigilance is needed for pneumothorax in MTB patients undergoing treatment.
- Early diagnosis and management of pneumothorax are crucial for patient outcomes.
- This case underscores the importance of considering rare complications in complex infectious diseases.
Related Concept Videos
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...